학술논문
Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: Efficacy and safety in previously treated Korean patients
Document Type
Article
Author
Source
In: Blood Research . (Blood Research, 2019, 54(3):198-203)
Subject
Language
English
ISSN
22880011
2287979X
2287979X